Clinical Trial Update: Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of pelabresib in patients with advanced cancers and hepatic impairment, sponsored by Novartis; the trial status is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Pelabresib (pelabresib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Advanced Malignancies and Hepatic Impairment | Phase 1 | Status: NOT_YET_RECRUITING